K-pop

LE SSERAFIM to Appear on the U.S. 'Jennifer Hudson Show' for the Third Consecutive Year… to Perform New Song

Taking the Stage with "Made My Night" World Tour: North American Concert Preview

KIM HYUNSIK
2026-09-16 14:44:56
[Edaily Starin KIM HYUNSIK Reporter] Girl group LE SSERAFIM (Kim Chae-won, Sakura, Heo Yoon-jin, Kazuha, Hong Eun-chae) returned to "The Jennifer Hudson Show."
(
Photo courtesy of Source Music,
The Jennifer
Hudson Show
)
(Photo courtesy of Source Music, The Jennifer Hudson Show)
On the 15th (local time), LE SSERAFIM appeared on the popular U.S. talk show “The
Jennifer Hudson Show
” and performed their new song “Made My Night.”
This marks LE SSERAFIM’s third appearance on “The Jennifer Hudson Show,” following their appearances in 2024 and last year. Host and singer Jennifer Hudson welcomed them back, introducing them as “K-pop superstars.”
“Made My Night” is a pop-dance track that celebrates the joy of dancing all night with a special someone. It serves as the title track of their new single, released on the 11th.
As LE SSERAFIM performed their new song, some audience members stood up, sang along, and enjoyed the performance. The camera also captured audience members wearing T-shirts featuring photos of LE SSERAFIM. Toward the end of the performance, Jennifer Hudson caught the audience’s attention by attempting the “ending pose” characteristic of K-pop music shows.
After finishing their performance of the new song, LE SSERAFIM took time to answer questions from the audience and discuss the new song and their upcoming activities.
Referring to their North American world tour, which kicks off on the 16th at Crypto.com Arena in Los Angeles, they said, “It’s a show everyone can enjoy, so please look forward to it.”

Economy

Corporation

IT·Science

Economy

[Exclusive] Jeonbuk Bank Launches First Bitcoin-Linked Loan in the Domestic Banking Sector

Jeonbuk Bank, a subsidiary of JB Financial Group Co., Ltd.(175330), has become the first bank in South Korea to introduce won-denominated loans linked to digital assets. Initially, the service will be…
2026-10-12 09:35:03

Corporation

GENINUS Inc. Begins Experimental Validation of New Anti-Cancer Drug Target Identified by AI… 'Lays Groundwork for Technology Transfer'

GENINUS Inc.(389030)is embarking on experimental research to verify the feasibility of developing actual treatments based on new anti-cancer drug targets identified using artificial intelligence (AI).…
2026-10-12 08:01:02

IT·Science

Onconic Therapeutics Inc. Unveils 'OCN-501,' a New GLP-1 Combination Therapy for Obesity, for the First Time

#Onconic Therapeutics Inc. has unveiled a new drug candidate designed to reduce muscle loss that can occur during weight loss when used in combination with existing glucagon-like peptide-1 (GLP-1) cla…
2026-10-12 09:27:02